On the stock market since 2020, it operates in the world of health and science. It has 5,263 employees. Now — the numbers.
This is an established company with proven profits.
Average growth of 24% a year over the last 4 years. Red columns mark years that ended in a loss.
If every debt were paid off today, $47.5B would still be left in the vault — a solid cushion for hard times.
The stock trades 54% below its peak. The market has trimmed its expectations for the company.
Over the last 3 years, sales grew about 15% a year on average.
There is $48.2B in the vault; even if every debt were paid off, $47.5B would remain.
Since the drop from its peak, buyer appetite hasn’t come back.
On our five-subject report card, JDHIF sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: JDHIF is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.